Table 2.
Total | JR-NET 1 | JR-NET 2 | p | |
---|---|---|---|---|
n | 1,409 | 619 | 790 | |
IV t-PA (%) | 81/1,202 (6.7) | 4/441 (0.9) | 77/761 (10.1) | < 0.001 |
Endovascular procedures (%) | (n = 1,245) | (n = 471) | (n = 774) | < 0.001 |
Stand-alone IAT | 466 (37.4) | 223 (47.3) | 243 (31.4) | |
Stand-alone PTA/BCD | 199 (16.0) | 39 (8.3) | 160 (20.7) | |
Other single procedures | 64 (5.1) | 24 (5.1) | 40 (5.2) | |
IAT + PTA/BCD | 341 (27.4) | 135 (28.7) | 206 (26.6) | |
Other procedural combinations | 175 (14.1) | 50 (10.6) | 125 (16.1) | |
Any combination including IAT | 917 (73.7) | 388 (82.4) | 529 (68.3) | < 0.001 |
BCD: balloon clot disruption, IAT: intra-arterial thrombolysis, IV t-PA: intravenous thrombolysis using tissue plasminogen activator, JR-NET: Japanese Registry of Neuroendovascular Therapy, Other single procedures: includes stenting, thromboaspiration, clot retrieval and others, PTA: percutaneous transluminal angioplasty,.